Clinical Trial

Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity

Name: Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity — clinical trial record (NCT07564479)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To assess the nephroprotective efficacy of Alpha-Lipoic Acid in preventing cisplatin-induced nephrotoxicity in oncology patients by monitoring renal function changes

Trial Details

NCT Number	NCT07564479
Lead Sponsor	Minia University Collaborators: Minia University Hospital
Conditions	Cisplatin Nephrotoxicity, Nephrotoxicity
Enrollment	50 participants
Start Date	2026-03-10
Primary Completion	2027-03 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-05-04